Naltrexone/bupropion: an investigational combination for weight loss and maintenance.

2011 
Naltrexone/bupropion is an investigational combination for weight loss and maintenance in patients who are obese or have a BMI ≧ 27 kg/m2 with comorbid diabetes, hypertension or hyperlipidemia. Pooled results from four phase 3 trials reveal placebo-subtracted mean weight loss of 4.7% (range 3.2–5.2%) with naltrexone/bupropion after 1 year (p
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    13
    References
    15
    Citations
    NaN
    KQI
    []